By submitting this form, you are agreeing to the Terms of Use and Privacy Policy.
Coming soon
A portable electronic device known as an automated external defibrillator (AED) can automatically diagnose the life-threatening cardiac arrhythmias ventricular fibrillation (VF) and pulseless ventricular tachycardia (PVT) and treat them through defibrillation, which is the application of electricity to stop the arrhythmia and restore the heart’s normal rhythm.
AEDs are created to be user-friendly for lay people, with straightforward audio and visual directions, and the use of AEDs is covered in many first aid, certified first responder, and basic life support (BLS) level cardiopulmonary resuscitation (CPR) training.
SMART Pads track the first touch of the rescuer and direct the AED to adjust its instructions to match their precise speed. The voice instructions won’t overwhelm you, get in your way, or make you go more slowly.
The Global automated external defibrillator market accounted for $XX Billion in 2021 and is anticipated to reach $XX Billion by 2030, registering a CAGR of XX% from 2022 to 2030.
Cardiac Science, the US division of medical device manufacturer Opto Circuits India, has introduced a brand-new automated external defibrillator (AED) in North America.
Opto Circuits India stated in a filing to BSE that “The Powerheart G5 is the first FDA-cleared AED that combine fully automatic shock delivery…fast shock times to help save a sudden cardiac arrest (SCA) victim’s life.
“Customers desire AEDs that are simple to use, ready for usage, and equipped with cutting-edge technology, which has allowed the company to maintain price points, he noted. Opto Circuits India has previously stated that the Powerheart line of AEDs is made to allow rescuers to quickly administer efficient, life-saving therapy to aid a person who has experienced sudden cardiac arrest.
